This ASH 2025 conference video features expert perspectives on newly published ASH guidelines for the treatment of newly diagnosed older adults with acute myeloid leukemia (AML). Discussion focuses on individualized treatment selection, molecular risk–informed decision-making, assessment of transplant eligibility, and the role of supportive and end-of-life care.

The video also reviews real-world evidence evaluating anti-inflammatory approaches for the management of immune effector cell–associated neurotoxicity syndrome (ICANS) following CAR T-cell therapy, highlighting evolving strategies to address this challenging toxicity in clinical practice.

Share your thoughts

Watch as Virginia Kaklamani, MD, and E. Shelley Hwang, MD, discuss the latest breakthroughs in breast cancer care, including promising trials with the potential to lead to FDA approvals and a novel approach to treating DCIS. These insights from the San Antonio Breast Cancer Symposium highlight exciting progress in therapies and strategies shaping the future of breast oncology.

In this video, Mikkael A. Sekeres, MD, shares insights from the ASH 2024 meeting on groundbreaking studies in hematology, including promising results for pediatric ALL treatments and the potential of early intervention in myeloma. Dr. Satwanilapur discusses the five-year update on Axocell therapy for indolent lymphoma, demonstrating remarkable long-term survival and remission outcomes. Tune in for the latest breakthroughs in hematologic cancer treatments.